Brief: Pharmala Biotech Holdings Rua Bioscience And Pharmala Biotech Partner To Supply Medicinal Mdma In New Zealand
BRIEF-Pharmala Biotech Holdings Rua Bioscience And Pharmala Biotech Partner To Supply Medicinal Mdma In New Zealand Oct 8 (Reuters) - Pharmala Biotech Holdings Inc MDMA.CD:
PHARMALA BIOTECH HOLDINGS INC: RUA BIOSCIENCE AND PHARMALA BIOTECH PARTNER TO SUPPLY MEDICINAL MDMA IN NEW ZEALAND
PHARMALA BIOTECH - RUA TO IMPORT, DISTRIBUTE AND SELL PHARMALA'S LANEO MDMA IN NEW ZEALAND
PHARMALA BIOTECH - RUA TO SUPPLY 40 MG LANEO MDMA CAPSULES TO AUTHORISED PRESCRIBERS IN NEW ZEALAND
PHARMALA BIOTECH - FIRST SHIPMENT TO BE SUPPLIED ON CONSIGNMENT BASIS WITH MINIMAL UPFRONT CAPITAL
PHARMALA BIOTECH HOLDINGS: ON SEPT 1, CO & VERIDION SIGNED TERMINATION & MUTUAL RELEASE AGREEMENT
PHARMALA BIOTECH - TERMINATION ENDS EXCLUSIVE NEW ZEALAND DISTRIBUTION AGREEMENT DATED SEPTEMBER 21, 2025
Source text: ID:nGNX9NyvTZ
Further company coverage: MDMA.CD
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Pharmala Biotech Holdings
See all newsBrief: Pharmala Biotech Holdings Rua Bioscience And Pharmala Biotech Partner To Supply Medicinal Mdma In New Zealand
Brief: PharmAla Biotech Executes Definitive License Agreement Granting Jupiter Neurosciences Exclusive US Rights To Ala-002
Brief: Pharmala Biotech Executes Definitive Agreement To Form Special Purpose Vehicle, Restora Neurosciences, For Clinical Development Of Patented Novel Mdxx Molecule Apa-01
Brief: Pharmala Executes Binding Letter Of Intent For Formation Of Special Purpose Vehicle To Develop Patented Novel Mdxx Molecule Apa-01
Brief: PharmALa Signs Supply & Data Agreement With Nautilus Sanctuary For Phase 2 Mdma Clinical Trial Treating Post-Traumatic Stress And Adjustment Disorder In Frontline Healthcare Workers And First Responders